Evaluating the feasibility of prolonged-release buprenorphine formulations as an alternative to daily opioid agonist therapy regardless of prior treatment adherence: a pilot study

Table 2 Treatment response classification criteria

Treatment response	Criteria
Complete response	• Full adherence to treatment schedule • No detected or self-reported on-top drug use
Partial response	• Full adherence to treatment schedule • Some detected or self-reported on-top drug use
No response	• Withdrawal from PRB treatment or missed doses • Some detected or self-reported on-top drug use

ISSN: 2055-5784